Evidence map›Paper›PMID 30816313›Full record

ArticleScientific reports2019

Isolation of gene-edited cells via knock-in of short glycophosphatidylinositol-anchored epitope tags.

Anastasia Zotova, Alexey Pichugin, Anastasia Atemasova, Ekaterina Knyazhanskaya, Elena Lopatukhina, Nikita Mitkin, Ekhson Holmuhamedov, Marina Gottikh, Dmitry Kuprash, Alexander Filatov and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Anastasia ZotovaCell and Gene Technology Group, Institute of Gene Biology RAS, Moscow, Russia.
Alexey PichuginNRC Institute of Immunology FMBA of Russia, Moscow, Russia.ORCID 0000-0001-5356-3331
Anastasia AtemasovaCell and Gene Technology Group, Institute of Gene Biology RAS, Moscow, Russia.
Ekaterina KnyazhanskayaChemistry Department, Lomonosov Moscow State University, Moscow, Russia.
Elena LopatukhinaFaculty of Biology, Lomonosov Moscow State University, Moscow, Russia.
Nikita MitkinLaboratory of Intracellular Signaling in Health and Disease, Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.ORCID 0000-0002-1014-9250
Ekhson HolmuhamedovInstitute of Theoretical and Experimental Biophysics RAS, Pushchino, Russia.
Marina GottikhChemistry Department, Lomonosov Moscow State University, Moscow, Russia.
Dmitry KuprashLaboratory of Intracellular Signaling in Health and Disease, Engelhardt Institute of Molecular Biology RAS, Moscow, Russia.
Alexander FilatovNRC Institute of Immunology FMBA of Russia, Moscow, Russia.
Dmitriy MazurovCell and Gene Technology Group, Institute of Gene Biology RAS, Moscow, Russia. dvmazurov@yandex.ru.
Lomonosov Moscow State University · RUInstitute of Immunology and Physiology · RUEngelhardt Institute of Molecular Biology · RUInstitute of Theoretical and Experimental Biophysics · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We describe Surface Oligopeptide knock-in for Rapid Target Selection (SORTS), a novel method to select mammalian cells with precise genome modifications that does not rely on cell cloning. SORTS is designed to disrupt the target gene with an expression cassette encoding an epitope tag embedded into human glycophosphatidylinositol (GPI)-anchored protein CD52. The cassette is very short, usually less than 250 nucleotides, which simplifies donor DNA construction and facilitates transgene integration into the target locus. The chimeric protein is then expressed from the target promoter, processed and exposed on the plasma membrane where it serves as a marker for FACS sorting with tag-specific antibodies. Simultaneous use of two different epitope tags enables rapid isolation of cells with biallelic knock-ins. SORTS can be easily and reliably applied to a number of genome-editing problems such as knocking out genes encoding intracellular or secreted proteins, protein tagging and inactivation of HIV-1 provirus.

Indexed as

CD52 AntigenCell Line, TumorEpitopesGene EditingGene Knock-In TechniquesGene Knockout TechniquesGenes, ReporterGenetic VectorsHEK293 CellsHumansPromoter Regions, GeneticTransgenesCD52 AntigenCD52 protein, humanEpitopes

Identifiers

PMID30816313
PMCPMC6395743
OpenAlexW2916216963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.